Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00474929 · BASELINE

Baseline characteristics

Sorafenib and Everolimus in Treating Patients With Relapsed or Refractory Lymphoma or Multiple Myeloma · Source last updated 2019-08-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      6
    2. group Id
      BG001
      value
      5
    3. group Id
      BG002
      value
      5
    4. group Id
      BG003
      value
      5
    5. group Id
      BG004
      value
      77
    6. group Id
      BG005
      value
      98
    units
    Participants
groups
  1. description
    Phase I: Dose level 0: Sorafenib 200 mg twice daily, RAD001 5mg every other day;
    id
    BG000
    title
    Phase I, Dose Level 0
  2. description
    Phase I: Dose level 1: Sorafenib 200 mg twice daily, RAD001 5mg every day
    id
    BG001
    title
    Phase I, Dose Level 1
  3. description
    Phase I: Dose level 2: Sorafenib 400 mg twice daily, RAD001 5mg every day
    id
    BG002
    title
    Phase I, Dose Level 2
  4. description
    Phase I: Dose level 3: Sorafenib 400 mg twice daily, RAD001 10mg every day
    id
    BG003
    title
    Phase I, Dose Level 3
  5. description
    Phase II: Sorafenib 200 mg twice daily, RAD001 5mg every day;
    id
    BG004
    title
    Phase II
  6. description
    Total of all reporting groups
    id
    BG005
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          22
          upper Limit
          64
          value
          43
        2. group Id
          BG001
          lower Limit
          50
          upper Limit
          67
          value
          63
        3. group Id
          BG002
          lower Limit
          43
          upper Limit
          63
          value
          56
        4. group Id
          BG003
          lower Limit
          24
          upper Limit
          69
          value
          61
        5. group Id
          BG004
          lower Limit
          22
          upper Limit
          83
          value
          61
        6. group Id
          BG005
          lower Limit
          22
          upper Limit
          83
          value
          61
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          3
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          1
        4. group Id
          BG003
          value
          1
        5. group Id
          BG004
          value
          30
        6. group Id
          BG005
          value
          36
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          3
        2. group Id
          BG001
          value
          4
        3. group Id
          BG002
          value
          4
        4. group Id
          BG003
          value
          4
        5. group Id
          BG004
          value
          47
        6. group Id
          BG005
          value
          62
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          6
        2. group Id
          BG001
          value
          5
        3. group Id
          BG002
          value
          5
        4. group Id
          BG003
          value
          5
        5. group Id
          BG004
          value
          77
        6. group Id
          BG005
          value
          98
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      6
    2. group Id
      BG001
      value
      5
    3. group Id
      BG002
      value
      5
    4. group Id
      BG003
      value
      5
    5. group Id
      BG004
      value
      77
    6. group Id
      BG005
      value
      98
    units
    Participants
groups
  1. description
    Phase I: Dose level 0: Sorafenib 200 mg twice daily, RAD001 5mg every other day;
    id
    BG000
    title
    Phase I, Dose Level 0
  2. description
    Phase I: Dose level 1: Sorafenib 200 mg twice daily, RAD001 5mg every day
    id
    BG001
    title
    Phase I, Dose Level 1
  3. description
    Phase I: Dose level 2: Sorafenib 400 mg twice daily, RAD001 5mg every day
    id
    BG002
    title
    Phase I, Dose Level 2
  4. description
    Phase I: Dose level 3: Sorafenib 400 mg twice daily, RAD001 10mg every day
    id
    BG003
    title
    Phase I, Dose Level 3
  5. description
    Phase II: Sorafenib 200 mg twice daily, RAD001 5mg every day;
    id
    BG004
    title
    Phase II
  6. description
    Total of all reporting groups
    id
    BG005
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          lower Limit
          22
          upper Limit
          64
          value
          43
        2. group Id
          BG001
          lower Limit
          50
          upper Limit
          67
          value
          63
        3. group Id
          BG002
          lower Limit
          43
          upper Limit
          63
          value
          56
        4. group Id
          BG003
          lower Limit
          24
          upper Limit
          69
          value
          61
        5. group Id
          BG004
          lower Limit
          22
          upper Limit
          83
          value
          61
        6. group Id
          BG005
          lower Limit
          22
          upper Limit
          83
          value
          61
    dispersion Type
    FULL_RANGE
    param Type
    MEDIAN
    title
    Age, Continuous
    unit Of Measure
    years
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          3
        2. group Id
          BG001
          value
          1
        3. group Id
          BG002
          value
          1
        4. group Id
          BG003
          value
          1
        5. group Id
          BG004
          value
          30
        6. group Id
          BG005
          value
          36
        title
        Female
      2. measurements
        1. group Id
          BG000
          value
          3
        2. group Id
          BG001
          value
          4
        3. group Id
          BG002
          value
          4
        4. group Id
          BG003
          value
          4
        5. group Id
          BG004
          value
          47
        6. group Id
          BG005
          value
          62
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex: Female, Male
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          6
        2. group Id
          BG001
          value
          5
        3. group Id
          BG002
          value
          5
        4. group Id
          BG003
          value
          5
        5. group Id
          BG004
          value
          77
        6. group Id
          BG005
          value
          98
      title
      United States
    param Type
    NUMBER
    title
    Region of Enrollment
    unit Of Measure
    participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice